FLRY3.SA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:07):

Stats
Dagens volum	0.00
Gjennomsnittsvolum	3.18M
Markedsverdi	7.96B
EPS	BRL0 ( 2024-03-08 )
Neste inntjeningsdato	( BRL0.310 ) 2024-05-09
Last Dividend	BRL0 ( N/A )
Next Dividend	BRL0 ( N/A )
P/E	16.60
ATR14	BRL0.0140 (0.10%)

Volum Korrelasjon

Lang: -0.02 (neutral)

Kort: 0.59 (weak)

Signal:(62.507) Neutral

Fleury S.A. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Fleury S.A. Korrelasjon - Valuta/Råvare

0.80
( moderate )

0.76
( moderate )

0.00
( neutral )

-0.79
( moderate negative )

-0.44
( neutral )

Fleury S.A. Økonomi

Annual	2023
Omsetning:	BRL6.47B
Bruttogevinst:	BRL1.59B (24.54 %)
EPS:	BRL0.870

FY	2023
Omsetning:	BRL6.47B
Bruttogevinst:	BRL1.59B (24.54 %)
EPS:	BRL0.870

FY	2022
Omsetning:	BRL4.46B
Bruttogevinst:	BRL1.21B (27.11 %)
EPS:	BRL0.910

Financial Reports:

No articles found.

Fleury S.A.

Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and image exam, diagnostic information, check-up and reference laboratory, genomics, clinic day, center of infusions, dental imaging exam, dental radiology, and diagnostic imaging services. The company also offers Saúde I, a digital healthcare platform that provides services, including teleconsultations, medical, diagnostic medicine exams, and procedures; and corporate solutions and face-to-face primary care, as well as solutions for physicians with digital office and medical education. It operates 284 customer service units and 31 hospital-based units under the Labs a+, Felippe Mattoso, Lafe, Fleury, a+SP, CIP, Moacir Cunha, Vita, inlab, Weinmann, Serdil, a+ and Diagmax, a+, IRN / CPC, Diagnosis a+, a+BA, and Pretti and Bioclinic brand names. The company was founded in 1926 and is headquartered in São Paulo, Brazil.